Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Peringkat dalam Saham #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Harga Saham
$0.0001
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$150.00
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Poniard Pharmaceuticals, Inc. (PARD)

Kategori

Harga PARD dengan kapitalisasi pasar B
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Kapitalisasi pasar dari Poniard Pharmaceuticals, Inc.(PARD)
Kapitalisasi Pasar: $150.00
Per August 2026, Poniard Pharmaceuticals, Inc. memiliki kapitalisasi pasar sebesar $150.00. Ini menjadikan Poniard Pharmaceuticals, Inc. sebagai perusahaan 42765th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Poniard Pharmaceuticals, Inc. dari 1988 hingga 2026
PARD dibandingkan dengan 5 teratas stocks paling populer
Harga PARD Aset B Pasar B Hasil
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,326 $150.00
$5.426T +3,617,325,682,222.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,957,936 $150.00
$4.437T +2,957,935,582,593.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,766,258 $150.00
$4.149T +2,766,257,604,808.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,442,560 $150.00
$3.664T +2,442,560,416,900.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,926,166 $150.00
$2.889T +1,926,166,325,900.00%